“…At the structural level, SGCs appear to change morphology (Pannese, ) and to undergo proliferation (Donegan, Kernisant, Cua, Jasmin, & Ohara, ; Friede & Johnstone, ; Lu & Richardson, ; Shinder et al, ; Vit, Jasmin, Bhargava, & Ohara, ), as well as to increase inter‐SGC coupling via gap junctions (Cherkas et al, ; Hanani, Huang, Cherkas, Ledda, & Pannese, ; Huang, Cherkas, Rosenthal, & Hanani, ; Pannese, Ledda, Cherkas, Huang, & Hanani, ; Spray et al, ; Suadicani et al, ). Upregulation of glial fibrillary acidic protein (GFAP) is also described (Liu et al, ; Vit et al, ; Woodham, Anderson, Nadim, & Turmaine, ), which is often used as a marker for activated SGCs (Blum, Procacci, Conte, Sartori, & Hanani, ; Gunjigake, Goto, Nakao, Kobayashi, & Yamaguchi, ; Hanani, Blum, Liu, Peng, & Liang, ; Nadeau, Wilson‐Gerwing, & Verge, ; Ohara et al, ; Ohtori, Takahashi, Moriya, & Myers, ). Furthermore, a decreased expression of the K + channel Kir4.1 is believed to promote hyperexcitability and sensitization of peripheral neurons, which ultimately contributes to neuropathic pain (Takeda, Takahashi, Nasu, & Matsumoto, ; Vit et al, ; Vit, Ohara, Bhargava, Kelley, & Jasmin, ).…”